Moreover, we document a higher BCR responsiveness to IgM modulation in a subset of MCL patients’ samples, with all the analyzed phosphoproteins (but pNF-κB p65) responding more actively compared with the remaining MCL samples. Here, BCR is linked to mantle cell lymphoma.